µÚËľüÒ½´óѧһ¾Å¾Å¶þÄê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧÊÔÌâ ѧ¿Æ×¨Òµ£º ~U3Seo }
ki#b
PgT
´«È¾²¡Ñ§ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ LZa
%
x
mqw 84u
Ò». Ãû´Ê½âÊÍ(ÿÌâ4·Ö,¹²32·Ö) (-J<Vy]
1fR P1
1. ICAM-1 2LC
w*eT{)
C99&L3bz^(
2. interleukin 12(IL-12) 7f*
RM
j_V/GnEQ
3. tumor infiltrating lymphocyte %I0}4$
x)5LT}p
4. TCR/CD3 complex >jKjh!`)!e
#D0 ~{H
5. hematopoietin receptor family R>HY:-2
^cn@?k((A
6. individual idiotype(IdI) A%n?}
NNp}|a9
7. integrin $
9 =8@
32^#RlSu8
8. colony-stimulatory factor (CSF) - wWRm
Eu4 &-i
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© C`EY5"N r
'kEG.Oq7
1. ÃâÒßÇòµ°°×ÖØÁ´µÄ»ùÒòÈçºÎ½øÐÐÀà±ðת»»(class switching )? s~Gw
*(Ro;?O,pi
2. ¼òÊöɱÉËÐÔTϸ°û(Tc)ɱÉ˲¡¶¾¸ÐȾ°Ðϸ°ûµÄ»úÀí¡£ s`1^*Dl%+
AK;^9b-}q:
3. ÉúÎïÓ¦´ðµ÷½Ú¼Á( biological response modifier,BRM)Ö÷ÒªÓÐÄļ¸Àà?¼òÒª½éÉÜÔÚ´«È¾ÐÔ¼²²¡·ÀÖÎÖеÄ×÷ÓᣠF|*tNJU>
Gnv!]c&S>l
4. ¼òÊö¿¹ÔÌá³Êϸ°û(APC)Ó븨ÖúÐÔTϸ°û(Th)Ï໥×÷ÓõĹØÏµ¡£ y@aKNWy}$
+f$Z-U1H/
Èý. ÎÊ´ðÌâ(ÿÌâ18·Ö,¹²36·Ö) @ t|3gF$X
dQK`sLChv
1. ÊÔÊö¸ÉÈÅËØµÄ·ÖÀ༰ÆäÉúÎïѧ×÷ÓÃÌØµã¡£Ö÷Òª¿ÉÒÔÖÎÁÆÄÄЩ´«È¾ÐÔ¼²²¡?¼òÊö¸ÉÈÅËØ¼ì²âµÄ·½·¨ºÍÔÀí¡£ 5{>>,pP&
C=yD3mVz
2. ºÎΪ»ùÒò¹¤³Ì¿¹Ìå?Ŀǰ¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? µÚËľüÒ½´óѧһ¾Å¾ÅÈýÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: ´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 1. CD4 2. T cell receptor(TCR) 67?n-NP
8$m1eQ`{
3. immunoglobulin superfamily (IgSF) Bj8<@~bX:L
Q0WY$w1<
4. selectin ~b#OFnyG
ftaBilkjp
5. anti-idiotypic antibody (¦ÁId) 1OP"5f
UO1$UF!
QC
6. major histocompatibility complex(MHC) -$9
~xX
1J&\,f&
7. immunotolerance *l{4lu
1@@y]s_.a
8. biological reponse modifier(BRM) Rf?%Tv0\
0Nt%YP
9. immune reponse gene (Ir gene) nd;O(s;
F:_FjxU
10. reshaped antibody (or reconstituted antibody) CC>($k"
i(P>Y2s
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© 80HEAv,O
d=F)y~&'
1. ¼òÊö°×ϸ°û½éËØ6(IL-6)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¡£ $YP
QC
c8q G\\t[
2. ϸ°û¶¾ÐÔTÁܰÍϸ°û(Tc»òCTL)Ó뿹ÌåÒÀÀµµÄϸ°û½éµ¼µÄϸ°û¶¾(ADCC)ɱÉË»úÀíÓкβ»Í¬? %]!?{U\*k
0f{IE@-b
3. ¼òÊöµÚ¢ôÐÍ(³Ù·¢ÐÍ)±ä̬·´Ó¦µÄ·¢Éú»úÀí¡£ soDfi-2o3
8TI#7
4. NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄ±íÃæ±ê¼Ç?NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄÉúÎïѧ»îÐÔ? 6# R;HbkO
PYaOH_X.
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö) ¹©´«È¾²¡Ñ§×¨ÒµÊÔÌ⣺ t:disL&!E
TD%WJ9K\
1. »úÌåÓÐÄÄЩÃâÒßϸ°ûºÍÃâÒß·Ö×Ó²ÎÓ뿹²¡¶¾¸ÐȾ?ËüÃÇÊÇÈçºÎ·¢»Ó²¡¶¾ÃâÒß×÷ÓõÄ? *%nX#mwz
4 #G3ew
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚ²¡¶¾Ñ§ÖÐÓÐÄÄЩÖ÷ÒªÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ q4 $sc_0i
u$\Tg3du2
¹©Ïû»¯ÄÚ¿Æ×¨ÒµÊÔÌ⣺ y^3,X_0
iKY-;YK
1. ĿǰÌåÄÚºÍÌåÍâ¼ì²âÖ×Áö»¼ÕßÃâÒß¹¦Äܵķ½·¨Ö÷ÒªÓÐÄÄЩ?·Ö±ðÐðÊöÿÖÖ·½·¨µÄÔÀíºÍ½á¹û²â¶¨? ,I=O"z>9
Z"+(LO!
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚÖ×ÁöѧÖÐÓÐÄÄЩÖ÷ÒªµÄÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ IK85D>00T
m[{nm95QZ
µÚËľüÒ½´óѧһ¾Å¾ÅËÄÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: JW2W>6Dgv[
WI%zr2T
´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: cz$c)It
{XyG1
̉񧄤 ud5x$`
o
K%K+h
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© {3jm%ex
N <ja6Ac
1. CD8 H)-L%l|9
;H`=):U
2. T cell receptor ¦Á and ¦Â chain (TCR¦Á¦Â ) l@(t^68OD
i_'|:Uy*F
3. immunoglobulin fold(Ig fold) G;87in ,}
-(`K7T>D.
4. cadherin (Ca-dependent cell adhesion moleculers) MAl{
66
mOABZ#+F
k
5. idiotype-anti-idiotypic antibody immune network theory \;4L~_2$q
Q3'(f9
x
6. HLA class II antigen +F#=`+V
7/$nA<
qM
7. complementarity-determining region (CDR) +ytT)S
WMt&8W5
8. perforin(or pore-forming protein ,PFP) eA;j/&qH
:..E:HdYO
9. high affinity IL-2 receptor 9u-M! $
'US8"83
10. artificial active immunization BZnp
#}f
b7F3]W<`&